Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T16:45:53.989Z Has data issue: false hasContentIssue false
  • English
  • Français

First-Episode Psychosis care in Central Europe: What we have learned and what we still need to do

Published online by Cambridge University Press:  01 September 2022

J. Réthelyi
J. Réthelyi*
Affiliation:
Semmelweis University, Department Of Psychiatry And Psychotherapy, Budapest, Hungary

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

First Episode Psychosis (FEP) treatment is a critical element of mental health-care systems, which has been shown to improve outcomes in this patient group. Due to divergent historical and political trajectories, countries of Central and Eastern Europe have taken a different course in the development of mental health-care. Among these differences is the less advanced level of present FEP treatment networks. Traditionally mental health-care is more inpatient based in these countries, with a lesser emphasis on specialized outpatient services, and early intervention programmes have been only launched during the last 15 years. Despite the lag of the development of FEP services, a variety of models has been already started in our countries. In my lecture I will review the literature about the Central and Esteran European region. I will also present good practices of how the existing early intervention programmes can be integrated into the traditional mental health-care systems.

Disclosure

No significant relationships.

Keywords

early interventionFirst Episode PsychosisCentral and Eastern Europe
Type
Clinical/Therapeutic
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S23
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.